AG
IRWD icon

Algert Global’s Ironwood Pharmaceuticals IRWD Stock Holding History

Algert Global’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-122,580
Closed -$161K – 1233
2025
Q3 		$161K Hold
122,580
– – ﹤0.01% 1059
2025
Q2 		$88K Buy
+122,580
New +$96.2K ﹤0.01% 1143
2024
Q3 		– Sell
-14,200
Closed -$93K – 1376
2024
Q2 		$93K Buy
+14,200
New +$100K ﹤0.01% 1397
2022
Q2 		– Sell
-36,263
Closed -$456K – 1295
2022
Q1 		$456K Buy
+36,263
New +$416K 0.03% 840
2021
Q4 		– Sell
-13,024
Closed -$170K – 1034
2021
Q3 		$170K Buy
+13,024
New +$168K 0.02% 933
2019
Q4 		– Sell
-38,673
Closed -$332K – 412
2019
Q3 		$332K Buy
+38,673
New +$376K 0.12% 204

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Algert Global's IRWD Position: Q4 2025 in Review

Algert Global sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2025, closing a stake of 122,580 shares — an estimated $161K sold.

Algert Global first reported a position in IRWD in Q3 2019 and held it in 6 quarters. The position peaked at $456K in Q1 2022. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.

  • Algert Global reported no remaining Ironwood Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 122,580 Ironwood Pharmaceuticals shares in Q4 2025, an estimated $161K.
  • Algert Global first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 6 quarters.
  • Algert Global's Ironwood Pharmaceuticals position peaked at $456K in Q1 2022.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.